Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 ,inter alia, to consider and approve Intimation ....
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has informed the stock exchanges that its Board of Directors will meet on Wednesday, 25 February 2026. At this meeting, the Board will consider and approve the audited financial results for the quarter and financial year ended 31 December 2025. Additionally, the Board may consider recommending a dividend, if any, for FY ended 31 December 2025. This follows an earlier intimation dated 17 February 2026 about the scheduled board meeting.
This is a routine advance intimation under SEBI listing rules. Investors should wait for the actual board outcome on 25 February 2026 — only then will the dividend amount (if any) and full-year results be confirmed, which could influence the stock price and shareholder payouts.